FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies
H1 Blog
JULY 30, 2024
This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.
Let's personalize your content